Overweight and obesity are defined as abnormal or excessive amounts of fat that pose a threat to health. Overweight is defined as having a body mass index (BMI) above 25, and obesity as having a BMI over 30. It is one of the most prevalent disease conditions across the world. It affects individuals in developed, emerging, and undeveloped regions. The weight loss and obesity management services involve the use of certain products such as dietary supplements, medications, surgical interventions, and fitness equipment. The World Health Organisation classifies a person as overweight or obese if their Body-Mass-Index is more than or equal to 25, and obese if it is larger than or equal to 30.
Market Dynamics
Increasing incidence of obesity in developed and developing economies around the world is expected to assist the growth of global weight loss and obesity management market during the forecast period. For instance, in March 2022, according to World Health Organization (WHO), stated that more than 1 billion people worldwide are obese which includes 650 million adults, 340 million adolescents and 39 million children. Moreover, increasing launch of weight management programs by key players in the market is expected to assist growth of the weight loss and obesity management market during the forecast period. For instance, April 2023, Teladoc Health, Inc., a multinational telemedicine and virtual healthcare company, announced the launch of Provider-Based Care for weight management and pre-diabetes programs. Provider-Based Care delivers a unique and integrated care experience for members, including access to a Teladoc Health physician for a personalized care plan, along with coaching for day-to-day guidance with actionable digital tools.
Key features of the study:
- This report provides an in-depth analysis of the global weight loss and obesity management market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global weight loss and obesity management market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Herbalife International of America, Inc., F. Hoffmann-La Roche Ltd, VIVUS LLC., Apollo Endosurgery, Inc., Duke Products & Services & Fitness Center, Ethicon Inc., Equinox, Inc., Kellogg Co., Life Time Fitness Inc., Medtronic, Nutrisystem, Inc., FOUND, Ro, OptiBiotix Online., PRISTYN CARE, Allurion, WW International, Inc., Amgen Inc., Meiji Holdings Co., Ltd., Boehringer Ingelheim International GmbH, Rhythm Pharmaceuticals, Inc., Altimmune, and Nestlé Health Science.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global weight loss and obesity management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global weight loss and obesity management market
Detailed Segmentation:
- Global Weight Loss And Obesity Management market, By Product & Services:
- Drugs
- Supplements
- Equipment
- Services
- Global Weight Loss And Obesity Management market, By Age Group :
- Children
- Adults
- Geriatric
- Global weight loss And obesity management market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Novo Nordisk A/S
- Takeda Pharmaceutical Company Limited
- Eisai Co., Ltd.
- Herbalife International of America, Inc.
- Hoffmann-La Roche Ltd
- VIVUS LLC.
- Apollo Endosurgery, Inc.
- Duke Products & Services & Fitness Center
- Ethicon Inc.
- Equinox, Inc.
- Kellogg Co.
- Life Time Fitness Inc.
- Medtronic
- Nutrisystem, Inc.
- FOUND
- Ro
- OptiBiotix Online.
- PRISTYN CARE
- Allurion
- WW International, Inc.
- Amgen Inc.
- Meiji Holdings Co., Ltd.
- Boehringer Ingelheim International GmbH
- Rhythm Pharmaceuticals, Inc.
- Altimmune
- Nestlé Health Science
